15-75917386-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_147188.3(FBXO22):c.620C>T(p.Thr207Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000551 in 1,579,604 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_147188.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO22 | NM_147188.3 | c.620C>T | p.Thr207Ile | missense_variant | 5/7 | ENST00000308275.8 | NP_671717.1 | |
FBXO22 | NM_012170.4 | c.620C>T | p.Thr207Ile | missense_variant | 5/6 | NP_036302.1 | ||
FBXO22 | XM_047432382.1 | c.308C>T | p.Thr103Ile | missense_variant | 4/6 | XP_047288338.1 | ||
FBXO22 | NR_037623.2 | n.567C>T | non_coding_transcript_exon_variant | 4/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO22 | ENST00000308275.8 | c.620C>T | p.Thr207Ile | missense_variant | 5/7 | 1 | NM_147188.3 | ENSP00000307833.3 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152200Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000143 AC: 34AN: 237026Hom.: 0 AF XY: 0.000124 AC XY: 16AN XY: 128988
GnomAD4 exome AF: 0.0000364 AC: 52AN: 1427404Hom.: 0 Cov.: 27 AF XY: 0.0000323 AC XY: 23AN XY: 711320
GnomAD4 genome AF: 0.000230 AC: 35AN: 152200Hom.: 0 Cov.: 33 AF XY: 0.000269 AC XY: 20AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 22, 2024 | The c.620C>T (p.T207I) alteration is located in exon 5 (coding exon 5) of the FBXO22 gene. This alteration results from a C to T substitution at nucleotide position 620, causing the threonine (T) at amino acid position 207 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at